BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19712999)

  • 1. Clostridium difficile infections among Jordanian adult hospitalized patients.
    Nasereddin LM; Bakri FG; Shehabi AA
    Am J Infect Control; 2009 Dec; 37(10):864-6. PubMed ID: 19712999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis.
    Kim H; Riley TV; Kim M; Kim CK; Yong D; Lee K; Chong Y; Park JW
    J Clin Microbiol; 2008 Mar; 46(3):1116-7. PubMed ID: 18199783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory diagnosis of antibiotic-associated diarrhea: a Polish pilot study into the clinical relevance of Clostridium difficile and Clostridium perfringens toxins.
    Pituch H; Obuch-Woszczatyński P; Wultańska D; van Belkum A; Meisel-Mikołajczyk F; Łuczak M
    Diagn Microbiol Infect Dis; 2007 May; 58(1):71-5. PubMed ID: 17300901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
    Shin BM; Lee EJ; Kuak EY; Yoo SJ
    Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
    Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B
    Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shedding of Clostridium difficile PCR ribotype 078 by zoo animals, and report of an unstable metronidazole-resistant isolate from a zebra foal (Equus quagga burchellii).
    Álvarez-Pérez S; Blanco JL; Martínez-Nevado E; Peláez T; Harmanus C; Kuijper E; García ME
    Vet Microbiol; 2014 Mar; 169(3-4):218-22. PubMed ID: 24467928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary.
    Terhes G; Urbán E; Sóki J; Szikra L; Konkoly-Thege M; Vollain M; Nagy E
    Anaerobe; 2009 Dec; 15(6):237-40. PubMed ID: 19682411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile.
    Lemee L; Dhalluin A; Testelin S; Mattrat MA; Maillard K; Lemeland JF; Pons JL
    J Clin Microbiol; 2004 Dec; 42(12):5710-4. PubMed ID: 15583303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.
    Snydman DR; McDermott LA; Jacobus NV; Thorpe C; Stone S; Jenkins SG; Goldstein EJ; Patel R; Forbes BA; Mirrett S; Johnson S; Gerding DN
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6437-43. PubMed ID: 26239985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic trends in Clostridium difficile detection in Finnish microbiology laboratories.
    Könönen E; Rasinperä M; Virolainen A; Mentula S; Lyytikäinen O
    Anaerobe; 2009 Dec; 15(6):261-5. PubMed ID: 19591954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates.
    Zheng L; Citron DM; Genheimer CW; Sigmon SF; Carman RJ; Lyerly DM; Goldstein EJ
    Anaerobe; 2007; 13(3-4):114-20. PubMed ID: 17531516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital.
    Zumbado-Salas R; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E; Chaves-Olarte E
    Am J Trop Med Hyg; 2008 Aug; 79(2):164-5. PubMed ID: 18689617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report of Clostridium difficile NAP1/027 in a Mexican hospital.
    Camacho-Ortiz A; López-Barrera D; Hernández-García R; Galván-De Los Santos AM; Flores-Treviño SM; Llaca-Díaz JM; Maldonado-Garza HJ; Bosques-Padilla FJ; Garza-González E
    PLoS One; 2015; 10(4):e0122627. PubMed ID: 25915544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea.
    Shin BM; Kuak EY; Yoo SJ; Shin WC; Yoo HM
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):333-7. PubMed ID: 18082994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment.
    Tian TT; Zhao JH; Yang J; Qiang CX; Li ZR; Chen J; Xu KY; Ciu QQ; Li RX
    PLoS One; 2016; 11(3):e0151964. PubMed ID: 27011211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
    Sedigh Ebrahim-Saraie H; Heidari H; Amanati A; Bazargani A; Alireza Taghavi S; Nikokar I; Kalantar K; Motamedifar M
    Infez Med; 2018 Dec; 26(4):308-315. PubMed ID: 30555133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Clostridium difficile toxinotypes in infected patients at a tertiary care center in Lebanon.
    Moukhaiber R; Araj GF; Kissoyan KA; Cheaito KA; Matar GM
    J Infect Dev Ctries; 2015 Jul; 9(7):732-5. PubMed ID: 26230123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.